Literature DB >> 19669287

Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma.

Koichi Obara1, Nobuyuki Matsumoto, Masaru Okamoto, Minoru Kobayashi, Hiroki Ikeda, Hideaki Takahashi, Yoshiki Katakura, Kotaro Matsunaga, Toshiya Ishii, Chiaki Okuse, Michihiro Suzuki, Fumio Itoh.   

Abstract

BACKGROUND: Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is a thermoablative technique to kill tumor tissue by generating areas of coagulative necrosis. Recent reports have raised concern that RFA may lead to a local recurrence of HCC with an aggressive phenotype and unfavorable prognosis, suggesting that RFA may induce further malignant transformation of HCC. However, the biological effects of RFA on HCC cells have not been directly analyzed. The aim of this study was to determine whether heat stress of the type associated with RFA induces malignant transformation of HCC.
METHODS: We assessed the sensitivity of three HCC cell lines (HepG2, Alexander, and Huh7) to heat treatment for 10 min. We then determined the temperature at which a heat-resistant subline can be generated. We established and expanded sublines that survived heat treatment. And their proliferation rates, heat sensitivities, and invasive capacities were further examined.
RESULTS: All HepG2 died after 48 degrees C treatment, whereas 49 degrees C treatment was required to kill all Alexander and HuH7. We generated 20 sublines for each parental cell line. A HepG2 subline, HepG2#18, proliferated 100% faster than parental HepG2. Moreover, HepG2#18 survived after 50 degrees C treatment, whereas all parental HepG2 died after heat treatments at 48 degrees C or higher.
CONCLUSION: Our results showed that even a single heat treatment could induce further transformation of an HCC cell line. Our results suggest that an insufficient treatment of HCC by RFA that enables survival of some cells might induce further malignant transformation in vivo.

Entities:  

Year:  2008        PMID: 19669287      PMCID: PMC2716878          DOI: 10.1007/s12072-007-9040-3

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  27 in total

1.  Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region.

Authors:  T Seki; T Tamai; K Ikeda; M Imamura; A Nishimura; N Yamashiki; T Nakagawa; K Inoue
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-03       Impact factor: 2.566

2.  Therapy of HCC-radiofrequency ablation.

Authors:  L Buscarini; E Buscarini
Journal:  Hepatogastroenterology       Date:  2001 Jan-Feb

3.  Immunohistochemical detection of hepatocellular carcinoma in the setting of ongoing necrosis after radiofrequency ablation.

Authors:  Tomoo Itoh; Yasuko Orba; Hidehiro Takei; Yusuke Ishida; Makoto Saitoh; Hideaki Nakamura; Takashi Meguro; Shoichi Horita; Miri Fujita; Kazuo Nagashima
Journal:  Mod Pathol       Date:  2002-02       Impact factor: 7.842

4.  Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.

Authors:  Manabu Morimoto; Kazuya Sugimori; Kazuhito Shirato; Atsushi Kokawa; Naohiko Tomita; Takafumi Saito; Noriko Tanaka; Akinori Nozawa; Masamichi Hara; Hisahiko Sekihara; Hiroshi Shimada; Toshio Imada; Katsuaki Tanaka
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

5.  Treatment of recurrent hepatocellular carcinoma by radiofrequency thermal ablation.

Authors:  N Nicoli; A Casaril; L Marchiori; G Mangiante; A R Hasheminia
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

6.  Morphological response and survival of hepatoma cells during fractionated hyperthermia: effect of glycerol.

Authors:  J van Rijn; J van den Berg; D H Schamhart; R van Wijk
Journal:  Radiat Res       Date:  1984-06       Impact factor: 2.841

7.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

8.  Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation.

Authors:  Andrea Ruzzenente; Giovanni De Manzoni; Matteo Molfetta; Silvia Pachera; Bruno Genco; Matteo Donataccio; Alfredo Guglielmi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Aggressive recurrence after radiofrequency ablation of liver neoplasms.

Authors:  Nazario Portolani; Guido Alberto Massimo Tiberio; Maurizio Ronconi; Arianna Coniglio; Sara Ghidoni; Giacomo Gaverini; Stefano Maria Giulini
Journal:  Hepatogastroenterology       Date:  2003 Nov-Dec

10.  Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Yasutsugu Takada; Masanao Kurata; Nobuhiro Ohkohchi
Journal:  Int J Clin Oncol       Date:  2003-10       Impact factor: 3.402

View more
  28 in total

Review 1.  Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  Eur Radiol       Date:  2019-04-08       Impact factor: 5.315

Review 2.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Discontinuous moving shot technique for conformal thermal ablation in an ex vivo porcine liver model.

Authors:  Ge Ma; Hao Chen; Jin Xu; Hong Pan; Muxin Yu; Yue Wang; Hui Xie; Wenbin Zhou; Shui Wang
Journal:  Diagn Interv Radiol       Date:  2021-05       Impact factor: 2.630

4.  Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1α signals.

Authors:  Jun Wan; Wei Wu; Yun Chen; Ningning Kang; Renquan Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-27       Impact factor: 3.848

5.  Needle track tumor seeding after radiofrequency ablation of a thyroid tumor.

Authors:  Chang Un Lee; Soo Jin Kim; Jin Yong Sung; Sung Hee Park; Semin Chong; Jung Hwan Baek
Journal:  Jpn J Radiol       Date:  2014-08-19       Impact factor: 2.374

6.  Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.

Authors:  Keiichi Ito; Shigeyoshi Soga; Kenji Seguchi; Yusuke Shinchi; Ayako Masunaga; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Hiroshi Shinmoto; Tatsumi Kaji; Tomohiko Asano
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

7.  Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.

Authors:  Shan Ke; Xue-mei Ding; Jian Kong; Jun Gao; Shao-hong Wang; Yan Cheng; Wen-bing Sun
Journal:  J Transl Med       Date:  2010-07-29       Impact factor: 5.531

8.  Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.

Authors:  Jian Kong; Jinge Kong; Bing Pan; Shan Ke; Shuying Dong; Xiuli Li; Aimin Zhou; Lemin Zheng; Wen-bing Sun
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

9.  Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.

Authors:  Shuying Dong; Jian Kong; Fandong Kong; Jinge Kong; Jun Gao; Liang Ji; Bing Pan; Lian Chen; Lemin Zheng; Wenbing Sun
Journal:  BMC Cancer       Date:  2015-11-30       Impact factor: 4.430

10.  After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.

Authors:  Jian Kong; Lingqun Kong; Jinge Kong; Shan Ke; Jun Gao; Xuemei Ding; Lemin Zheng; Huichuan Sun; Wenbing Sun
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.